Skip to main content

Table 2 Clinical metabolic characteristics between longevity and controls

From: Prevalence and clinical profile of metabolic syndrome in longevity: study from Guangxi Zhuang Autonomous Region, China

 

Longevity

Control

  

95%CI

 

n = 307(100%)

n = 486 (100%)

χ2

OR

Lower

Upper

P

AOB

17.3%

13.6%

2.002

0.753

0.508

1.116

0.157

Elevated BP

61.1%

38.9%

183.15

0.106

0.075

0.150

<.001

RFG

39.1%

7.2%

121.65

0.121

0.080

0.183

<.001

highTG

21.8%

35.6%

16.910

1.980

1.426

2.749

<.001

lowHDL-C

33.2%

10.7%

61.005

0.241

0.166

0.350

<.001

MetS

28.0%

5.1%

81.740

0.139

0.087

0.224

<.001

  1. 95%CI 95% Confidence Interval, AOB abdominal obesity, Elevated BP elevated blood pressure, RFG raised fasting glucose, highTG high triglyceride, low HDL-C low high-density lipoprotein cholesterol, MetS metabolic syndrome
Back to article page

BMC Geriatrics

ISSN: 1471-2318

Contact us